News: Home Page Research

Next Page »

New insight on oral cancer culprits

Wednesday, November 12th, 2014

Oral squamous cell carcinoma (OSCC) treatments have been slow to advance despite the aggressive nature of these tumors that commonly metastasize. Models for the development of improved OSCC therapeutics have also been scarce. Thomas Andl, Ph.D., Claudia Andl, Ph.D., and colleagues previously observed coordinated loss of connective molecules (E-cadherin) and growth factor (TGFbeta) signaling in […]

Study Finds New Role for Cell Factor

Friday, October 31st, 2014

Vanderbilt University investigators have discovered a new molecular mechanism that regulates the dynamics of microtubules, which form the cell’s internal skeleton. The unexpected finding, reported in Developmental Cell, has implications for cancer drug discovery,

Aspirin’s Protective Effect in Cancer Explained

Thursday, October 2nd, 2014

For years, scientists have known that regular aspirin use may reduce the risk of cancer. “Studies have shown that aspirin administration for five or more years reduces the incidence of all cancers by 38 percent,” said Pierre Massion, M.D., professor of Medicine and Cancer Biology and director of the Thoracic Program at Vanderbilt-Ingram Cancer Center. […]

Accuracy of Lung Imaging Varies by Region

Wednesday, September 24th, 2014

FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common, a recent study has found.

Study identifies genes tied to colon cancer

Friday, August 22nd, 2014

by Dagny Stuart Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role. Genetic factors identified to date explain only a small fraction of colorectal cancer (CRC), […]

Komen breast cancer research grants

Friday, August 1st, 2014

by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]

Study on breast cancer in East Asian women

Tuesday, July 29th, 2014

by Dagny Stuart A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. While breast cancer is one of the most common malignancies among women worldwide, most studies of the […]

Colon cancer’s protein signatures identified

Friday, July 25th, 2014

by Bill Snyder A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. The technological tour de force, described as the first integrated “proteogenomic” characterization of human cancer, was reported online this week by the journal Nature. It […]

Abramson lands breast cancer research award

Wednesday, July 23rd, 2014

by Dagny Stuart     Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]

Research bolstered by lung cancer foundation

Monday, July 21st, 2014

by Dagny Stuart The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Lovly is one of three recipients of the annual grants, which provide $300,000 over three years for lung cancer research. “This is a wonderful award and I […]